Immunogenicity 15895

summary
Sample ID
4136
Response
Positive
Tumor Type
Breast cancer
Gene Symbol
SLC3A2
Transcript ID
None
HLA INFO
DRB1*07:01
TCR INFO

CDR3ACVVSAAQAGTALIF

TRBVBV4-1

TRAVAV10

CDR3BCASSASTGRNQPQHF

T cell Tumor cell DRB1*07:01
sequence
Full length protein sequence (631 aa)
MELQP
1
PEASI
6
AVVSI
11
PRQLP
16
GSHSE
21
AGVQG
26
LSAGD
31
DSETG
36
SDCVT
41
QAGLQ
46
LLASS
51
DPPAL
56
ASKNA
61
EVTVE
66
TGFHH
71
VSQAD
76
IEFLT
81
SIDPT
86
ASASG
91
SAGIT
96
GTMSQ
101
DTEVD
106
MKEVE
111
LNELE
116
PEKQP
121
MNAAS
126
GAAMS
131
LAGAE
136
KNGLV
141
KIKVA
146
EDEAE
151
AAAAA
156
KFTGL
161
SKEEL
166
LKVAG
171
SPGWV
176
RTRWA
181
LLLLF
186
WLGWL
191
GMLAG
196
AVVII
201
VRAPR
206
CRELP
211
AQKWW
216
HTGAL
221
YRIGD
226
LQAFQ
231
GHGAG
236
NLAGL
241
KGRLD
246
YLSSL
251
KVKGL
256
VLGPI
261
HKNQK
266
DDVAQ
271
TDLLQ
276
IDPNF
281
GSKED
286
FDSLL
291
QSAKK
296
KSIRV
301
ILDLT
306
PNYRG
311
ENSWF
316
STQVD
321
TVATK
326
VKDAL
331
EFWLQ
336
AGVDG
341
FQVRD
346
IENLK
351
DASSF
356
LAEWQ
361
NITKG
366
FSEDR
371
LLIAG
376
TNSSD
381
LQQIL
386
SLLES
391
NKDLL
396
LTSSY
401
LSDSG
406
STGEH
411
TKSLV
416
TQYLN
421
ATGNR
426
WCSWS
431
LSQAR
436
LLTSF
441
LPAQL
446
LRLYQ
451
LMLFT
456
LPGTP
461
VFSYG
466
DEIGL
471
DAAAL
476
PGQPM
481
EAPVM
486
LWDES
491
SFPDI
496
PGAVS
501
ANMTV
506
KGQSE
511
DPGSL
516
LSLFR
521
RLSDQ
526
RSKER
531
SLLHG
536
DFHAF
541
SAGPG
546
LFSYI
551
RHWDQ
556
NERFL
561
VVLNF
566
GDVGL
571
SAGLQ
576
ASDLP
581
ASASL
586
PAKAD
591
LLLST
596
QPGRE
601
EGSPL
606
ELERL
611
KLEPH
616
EGLLL
621
RFPYA
626
A
631
Mutation Information
DNA mutation:
None
Peptide Range:
51 ~ 63
Mut AA position:
None (13 in Wild Type peptide)
Alignment
Wild Type:
"LLASSDPPALASKNAEVT
|||||||.|||||
Mutant:
-----DPPALASTNAEVT"
reference
clinic trial
Checkpoint Blockade

None

ACT

N

Vaccination

N

Curative Effect

tumor regression

experiment
minimal_peptide

Y

Antigen Type

peptide

T-cell Source

TILs

APC Type

B cells

Assay

ELISPOT